These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24754789)

  • 21. Molecular analysis of a thai beta-thalassaemia heterozygote with normal haemoglobin A2 level: implication for population screening.
    Fucharoen S; Fucharoen G; Sanchaisuriya K; Pengjam Y
    Ann Clin Biochem; 2002 Jan; 39(Pt 1):44-9. PubMed ID: 11853188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.
    Karimi M; Jamalian N; Yarmohammadi H; Askarnejad A; Afrasiabi A; Hashemi A
    J Med Screen; 2007; 14(2):62-6. PubMed ID: 17626703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of haematological alterations on thalassaemia investigation in HIV-1-infected Thai patients receiving antiretroviral therapy.
    Pornprasert S; Leechanachai P; Klinbuayaem V; Leenasirimakul P; Sukunthamala K; Thunjai B; Phusua A; Saetung R; Sanguansermsri T
    HIV Med; 2008 Oct; 9(8):660-6. PubMed ID: 18643855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of mean corpuscular volume and mean corpuscular haemoglobin in screening for beta-thalassaemia trait.
    Mamtani M; Jawahirani A; Rughwani V; Das K; Kulkarni H
    Acta Haematol; 2006; 116(3):223-5. PubMed ID: 17016046
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of a prenatal screening procedure for beta-thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV).
    Ghosh A; Woo JS; Wan CW; Machenry C; Wong V; Ma HK; Chan V; Chan TK
    Prenat Diagn; 1985; 5(1):59-65. PubMed ID: 3975223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ICSH recommendations for the measurement of haemoglobin A2.
    Stephens AD; Angastiniotis M; Baysal E; Chan V; Fucharoen S; Giordano PC; Hoyer JD; Mosca A; Wild B;
    Int J Lab Hematol; 2012 Feb; 34(1):1-13. PubMed ID: 21974826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility and importance of accurate Hb A2 measurements for defining a strategy for β-thalassemia screening: experience in the Balearic Islands, Spain.
    López-Escribano H; Parera MM; Guix P; Castro JA; Ramon M; Picornell A
    Hemoglobin; 2013; 37(6):593-8. PubMed ID: 23952214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening criteria for beta thalassaemia trait in pregnant women.
    Rogers M; Phelan L; Bain B
    J Clin Pathol; 1995 Nov; 48(11):1054-6. PubMed ID: 8543631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal screening and prenatal diagnosis of thalassaemia.
    Hendy JG; Monagle PT; Bowden DK
    Med J Aust; 1999 Jun; 170(12):621, 623-4. PubMed ID: 10416439
    [No Abstract]   [Full Text] [Related]  

  • 30. Proposed screening criteria for beta-thalassemia trait during early pregnancy in southern China.
    Liao C; Xie XM; Zhong HZ; Zhou JY; Li DZ
    Hemoglobin; 2009; 33(6):528-33. PubMed ID: 19958202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for thalassemia carriers in populations with a high rate of iron deficiency: revisiting the applicability of the Mentzer Index and the effect of iron deficiency on Hb A2 levels.
    Amid A; Haghi-Ashtiani B; Kirby-Allen M; Haghi-Ashtiani MT
    Hemoglobin; 2015; 39(2):141-3. PubMed ID: 25806419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta-thalassemia in Cyprus.
    Pavlou E; Phylactides M; Kyrri A; Kalogerou E; Makariou C; Georgiou I; Kleanthous M
    Hemoglobin; 2006; 30(4):455-62. PubMed ID: 16987800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HbA2 levels in normal, beta-thalassaemia and haemoglobin E carriers by capillary electrophoresis.
    Hafiza A; Malisa MY; Khirotdin RD; Azlin I; Azma Z; Thong MC; Ali IM; Yeoh ZN; Mohd Ishak L; Mohd Radzi NR; Hussin NH
    Malays J Pathol; 2012 Dec; 34(2):161-4. PubMed ID: 23424780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Hb A2 values in an HIV-1-infected patient receiving antiretroviral drugs: a pitfall for thalassemia antenatal diagnosis.
    Pornprasert S; Sukunthamala K; Leechanachai P; Sanguansermsri T
    Hemoglobin; 2009; 33(2):158-61. PubMed ID: 19373594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of antenatal patients in a multiethnic community for beta thalassaemia trait.
    Bain BJ
    J Clin Pathol; 1988 May; 41(5):481-5. PubMed ID: 3384979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Iron Deficiency on the Phenotype of β-Thalassaemia Trait.
    Arshad M; Ahmed S; Ali N
    J Coll Physicians Surg Pak; 2016 Mar; 26(3):230-1. PubMed ID: 26975960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal diagnosis of beta-thalassemia/Hb E by hemoglobin typing compared to DNA analysis.
    Sirichotiyakul S; Saetung R; Sanguansermsri T
    Hemoglobin; 2009; 33(1):17-23. PubMed ID: 19205969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of capillary electrophoresis to determine hemoglobin A2 in healthy adults and alpha- and beta-thalassemia carriers].
    Hua L; Li J; Liu ZY; Zhong HZ; Liao C; Xu XM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):421-4. PubMed ID: 14556197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn bloodspot results: predictive value of screen positive test for thalassaemia major.
    Streetly A; Latinovic R; Henthorn J; Daniel Y; Dormandy E; Darbyshire P; Mantio D; Fraser L; Farrar L; Will A; Tetlow L
    J Med Screen; 2013 Dec; 20(4):183-7. PubMed ID: 24277229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.